Product Name

  • Name

    Primaquine diphosphate

  • EINECS 200-560-8
  • CAS No. 63-45-6
  • Article Data2
  • CAS DataBase
  • Density
  • Solubility moderately soluble in water
  • Melting Point 199-205 °C
  • Formula C15H21N3O.2(H3PO4)
  • Boiling Point 451.1 °C at 760 mmHg
  • Molecular Weight 455.342
  • Flash Point 226.6 °C
  • Transport Information UN 2811 6.1/PG 3
  • Appearance orange powder
  • Safety 45
  • Risk Codes 25
  • Molecular Structure Molecular Structure of 63-45-6 (Primaquine diphosphate)
  • Hazard Symbols ToxicT
  • Synonyms Prestwick_406;[(4S)-4-[(6-methoxyquinolin-8-yl)amino]pentyl]azanium;Primaquine phosphate (USP);Quinoline, 8-[ (4-amino-1-methylbutyl)amino]-6-methoxy-, phosphate (1:2);Primaquine (TN);N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid;1,4-Pentanediamine, N4- (6-methoxy-8-quinolinyl)-, phosphate (1:2);primaquine bis(phosphate);
  • PSA 235.31000
  • LogP 1.69880

Synthetic route

Primaquine
90-34-6

Primaquine

primaquine diphosphate
63-45-6

primaquine diphosphate

Conditions
ConditionsYield
With phosphoric acid In diethyl ether Darkness;
4-methoxy-2-nitroaniline
96-96-8

4-methoxy-2-nitroaniline

primaquine diphosphate
63-45-6

primaquine diphosphate

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: arsenic(V) oxide; phosphoric acid / 1 h / 100 °C / Darkness
2: hydrogen / 2585.81 Torr / Darkness
3: triethylamine / 6 h / 150 °C / Darkness
4: hydrazine / ethanol / 72 h / Reflux; Darkness
5: phosphoric acid / diethyl ether / Darkness
View Scheme
6-methoxy-8-nitroquinoline
85-81-4

6-methoxy-8-nitroquinoline

primaquine diphosphate
63-45-6

primaquine diphosphate

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: hydrogen / 2585.81 Torr / Darkness
2: triethylamine / 6 h / 150 °C / Darkness
3: hydrazine / ethanol / 72 h / Reflux; Darkness
4: phosphoric acid / diethyl ether / Darkness
View Scheme
6-methoxyquinolin-8-amine
90-52-8

6-methoxyquinolin-8-amine

primaquine diphosphate
63-45-6

primaquine diphosphate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triethylamine / 6 h / 150 °C / Darkness
2: hydrazine / ethanol / 72 h / Reflux; Darkness
3: phosphoric acid / diethyl ether / Darkness
View Scheme
N-phthalolylprimaquine
83532-78-9

N-phthalolylprimaquine

primaquine diphosphate
63-45-6

primaquine diphosphate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrazine / ethanol / 72 h / Reflux; Darkness
2: phosphoric acid / diethyl ether / Darkness
View Scheme
Z-Lys(Boc)-OH
2389-60-8

Z-Lys(Boc)-OH

primaquine diphosphate
63-45-6

primaquine diphosphate

4'-N-(Nε-boc-N-Cbz-lysyl)primaquine

4'-N-(Nε-boc-N-Cbz-lysyl)primaquine

Conditions
ConditionsYield
With benzotriazol-1-ol; triethylamine; dicyclohexyl-carbodiimide In dichloromethane; N,N-dimethyl-formamide 1.) 0 deg C, 4 h, 2.) RT, overnight;95%
2-chloro-4,6-dimethylpyrimidine-5-carboxylic acid ethyl ester
108381-23-3

2-chloro-4,6-dimethylpyrimidine-5-carboxylic acid ethyl ester

primaquine diphosphate
63-45-6

primaquine diphosphate

ethyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-4,6-dimethylpyrimidin-5-carboxylate

ethyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-4,6-dimethylpyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;95%
primaquine diphosphate
63-45-6

primaquine diphosphate

C15H19(2)H2N3O
1318851-87-4

C15H19(2)H2N3O

Conditions
ConditionsYield
With sulfuric acid; water-d2 at 95℃; for 8h; Temperature;95%
2-chloro-4-methyl-6-phenylpyrimidine-5-carboxylic acid ethyl ester
36746-07-3

2-chloro-4-methyl-6-phenylpyrimidine-5-carboxylic acid ethyl ester

primaquine diphosphate
63-45-6

primaquine diphosphate

ethyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-phenylpyrimidin-5-carboxylate

ethyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-phenylpyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;94%
primaquine diphosphate
63-45-6

primaquine diphosphate

acetic anhydride
108-24-7

acetic anhydride

N-acetyl-primaquine
77229-67-5

N-acetyl-primaquine

Conditions
ConditionsYield
In dichloromethane at 20℃; for 1h;92%
isopropyl 2-chloro-4-methyl-6-phenylpyrimidine-5-carboxylate
1448992-15-1

isopropyl 2-chloro-4-methyl-6-phenylpyrimidine-5-carboxylate

primaquine diphosphate
63-45-6

primaquine diphosphate

isopropyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-phenylpyrimidin-5-carboxylate

isopropyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-phenylpyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;92%
methyl 2-chloro-4,6-dimethylpyrimidine-5-carboxylate

methyl 2-chloro-4,6-dimethylpyrimidine-5-carboxylate

primaquine diphosphate
63-45-6

primaquine diphosphate

methyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-4,6-dimethylpyrimidin-5-carboxylate

methyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-4,6-dimethylpyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;92%
2-chloro-4-(4-fluorophenyl)-6-methylpyrimidine-5-carboxylic acid ethyl ester
1448992-18-4

2-chloro-4-(4-fluorophenyl)-6-methylpyrimidine-5-carboxylic acid ethyl ester

primaquine diphosphate
63-45-6

primaquine diphosphate

ethyl 4-(4-fluorophenyl)-2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methylpyrimidin-5-carboxylate

ethyl 4-(4-fluorophenyl)-2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methylpyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;91%
C15H14ClN3O4
1376766-60-7

C15H14ClN3O4

primaquine diphosphate
63-45-6

primaquine diphosphate

isopropyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-(4-nitrophenyl)pyrimidin-5-carboxylate

isopropyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-(4-nitrophenyl)pyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;91%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

primaquine diphosphate
63-45-6

primaquine diphosphate

tert-butyl (4-((6-methoxyquinolin-8-yl)amino)pentyl)carbamate

tert-butyl (4-((6-methoxyquinolin-8-yl)amino)pentyl)carbamate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 25℃;91%
Ethyl 2-chloro-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate

Ethyl 2-chloro-4-(4-methoxyphenyl)-6-methylpyrimidine-5-carboxylate

primaquine diphosphate
63-45-6

primaquine diphosphate

Ethyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-(4-methoxyphenyl)pyrimidin-5-carboxylate

Ethyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-(4-methoxyphenyl)pyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;90%
3,4-dibutoxy-3-cyclobutene-1,2-dione
2892-62-8

3,4-dibutoxy-3-cyclobutene-1,2-dione

primaquine diphosphate
63-45-6

primaquine diphosphate

C34H40N6O4
1487428-85-2

C34H40N6O4

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With triethylamine In methanol at 20℃; for 0.5h; Inert atmosphere;
Stage #2: 3,4-dibutoxy-3-cyclobutene-1,2-dione In methanol for 48h; Inert atmosphere; Reflux;
89%
C15H14ClN3O4
1376766-58-3

C15H14ClN3O4

primaquine diphosphate
63-45-6

primaquine diphosphate

isopropyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-(3-nitrophenyl)pyrimidin-5-carboxylate

isopropyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-(3-nitrophenyl)pyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;88%
2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-(diphenylmethyl)-4-methylpentanamide

2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-(diphenylmethyl)-4-methylpentanamide

primaquine diphosphate
63-45-6

primaquine diphosphate

N-(diphenylmethyl)-2-[({4-[(6-methoxyquinolin-8-yl)amino]pentyl}carbamoyl)-amino]-4-methylpentanamide

N-(diphenylmethyl)-2-[({4-[(6-methoxyquinolin-8-yl)amino]pentyl}carbamoyl)-amino]-4-methylpentanamide

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With sodium hydroxide In water pH=9 - 10;
Stage #2: 2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-(diphenylmethyl)-4-methylpentanamide In 1,4-dioxane at 20℃; Darkness;
87%
primaquine diphosphate
63-45-6

primaquine diphosphate

Primaquine
90-34-6

Primaquine

Conditions
ConditionsYield
With sodium hydroxide In water at 20℃; for 2h; pH=10; Darkness;86%
With water; sodium hydroxide Heating;60%
Stage #1: primaquine diphosphate With triethylamine In dichloromethane for 0.5h; Cooling with ice;
Stage #2: In 2,2'-iminobis[ethanol]
C15H14ClN3O4
1376766-59-4

C15H14ClN3O4

primaquine diphosphate
63-45-6

primaquine diphosphate

isopropyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-(2-nitrophenyl)pyrimidin-5-carboxylate

isopropyl 2-(4-(6-methoxyquinolin-8-ylamino)pentylamino)-6-methyl-4-(2-nitrophenyl)pyrimidin-5-carboxylate

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 20℃; for 48h; Inert atmosphere;85%
2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-[(4-chlorophenyl)(phenyl)methyl]-2-phenylacetamide

2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-[(4-chlorophenyl)(phenyl)methyl]-2-phenylacetamide

primaquine diphosphate
63-45-6

primaquine diphosphate

N-[(4-chlorophenyl)(phenyl)methyl]-2-[({4-[(6-methoxyquinolin-8-yl)amino]pentyl}carbamoyl)amino]-2-phenylacetamide

N-[(4-chlorophenyl)(phenyl)methyl]-2-[({4-[(6-methoxyquinolin-8-yl)amino]pentyl}carbamoyl)amino]-2-phenylacetamide

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With sodium hydroxide In water pH=9 - 10;
Stage #2: 2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-[(4-chlorophenyl)(phenyl)methyl]-2-phenylacetamide In 1,4-dioxane at 20℃; Darkness;
85%
(N-(4-((6-methoxyquinolin-8-yl)amino)pentyl)-1H-benzo[d][1,2,3]triazole-1-carboxamide)
1042740-40-8

(N-(4-((6-methoxyquinolin-8-yl)amino)pentyl)-1H-benzo[d][1,2,3]triazole-1-carboxamide)

primaquine diphosphate
63-45-6

primaquine diphosphate

1,3-bis(4-((6-methoxyquinolin-8-yl)amino)pentyl)urea
1267807-38-4

1,3-bis(4-((6-methoxyquinolin-8-yl)amino)pentyl)urea

Conditions
ConditionsYield
With sodium dithionite; triethylamine In dichloromethane at 65℃; Microwave irradiation; Darkness;84%
3,4-dibutoxy-3-cyclobutene-1,2-dione
2892-62-8

3,4-dibutoxy-3-cyclobutene-1,2-dione

primaquine diphosphate
63-45-6

primaquine diphosphate

C23H29N3O4
1487428-84-1

C23H29N3O4

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With triethylamine In methanol at 20℃; for 0.5h; Inert atmosphere;
Stage #2: 3,4-dibutoxy-3-cyclobutene-1,2-dione In methanol for 48h; Inert atmosphere; Reflux;
82%
primaquine diphosphate
63-45-6

primaquine diphosphate

cyclohexanone
108-94-1

cyclohexanone

mercaptoacetic acid
68-11-1

mercaptoacetic acid

4-{4-[(6-methoxyquinolin-8-yl)amino]pentyl}-1-thia-4-azaspiro[4.5]decan-3-one
1356475-81-4

4-{4-[(6-methoxyquinolin-8-yl)amino]pentyl}-1-thia-4-azaspiro[4.5]decan-3-one

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In toluene at 110℃; for 3h;80%
primaquine diphosphate
63-45-6

primaquine diphosphate

3,4-dimethoxy-3-cyclobutene-1,2-dione
5222-73-1

3,4-dimethoxy-3-cyclobutene-1,2-dione

3-methoxy-4-({4-[(6-methoxyquinolin-8-yl)amino]pentyl}amino)cyclobut-3-ene-1,2-dione

3-methoxy-4-({4-[(6-methoxyquinolin-8-yl)amino]pentyl}amino)cyclobut-3-ene-1,2-dione

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With triethylamine In methanol at 20℃; for 0.5h; Inert atmosphere;
Stage #2: 3,4-dimethoxy-3-cyclobutene-1,2-dione In methanol for 12h; Inert atmosphere; Reflux;
79%
octane-1,8-dioic acid
505-48-6

octane-1,8-dioic acid

primaquine diphosphate
63-45-6

primaquine diphosphate

N,N’-bis({4-[(6-methoxyquinolin-8-yl)amino]pentyl})octanediamide

N,N’-bis({4-[(6-methoxyquinolin-8-yl)amino]pentyl})octanediamide

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With triethylamine In dichloromethane
Stage #2: octane-1,8-dioic acid With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 20℃; for 24h;
78%
succinic acid
110-15-6

succinic acid

primaquine diphosphate
63-45-6

primaquine diphosphate

N,N'-bis({4-[(6-methoxyquinolin-8-yl)amino]pentyl})butanediamide

N,N'-bis({4-[(6-methoxyquinolin-8-yl)amino]pentyl})butanediamide

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With triethylamine In dichloromethane
Stage #2: succinic acid With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 20℃; for 24h;
77%
C35H44N6O13

C35H44N6O13

primaquine diphosphate
63-45-6

primaquine diphosphate

C44H60N8O11

C44H60N8O11

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl-formamide76%
1,5-pentanedioic acid
110-94-1

1,5-pentanedioic acid

primaquine diphosphate
63-45-6

primaquine diphosphate

N,N’-bis({4-[(6-methoxyquinolin-8-yl)amino]pentyl})pentanediamide

N,N’-bis({4-[(6-methoxyquinolin-8-yl)amino]pentyl})pentanediamide

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With triethylamine In dichloromethane
Stage #2: 1,5-pentanedioic acid With N-ethyl-N,N-diisopropylamine; HATU In dichloromethane at 20℃; for 24h;
73%
primaquine diphosphate
63-45-6

primaquine diphosphate

p-[(10-dihydroartemisininoxy)methyl]benzoic acid

p-[(10-dihydroartemisininoxy)methyl]benzoic acid

C38H49N3O7
1519728-36-9

C38H49N3O7

Conditions
ConditionsYield
Stage #1: p-[(10-dihydroartemisininoxy)methyl]benzoic acid With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; triethylamine In dichloromethane at 0℃; for 1h;
Stage #2: primaquine diphosphate With triethylamine In dichloromethane at 0 - 20℃;
72%
primaquine diphosphate
63-45-6

primaquine diphosphate

8-amino-6-hydroxyquinoline dihydrobromide

8-amino-6-hydroxyquinoline dihydrobromide

Conditions
ConditionsYield
With hydrogen bromide for 48h; Heating;71%
2-(1H-benzo[d][1,2,3]triazole-1-carbonyl)-N-(4-((6-methoxyquinolin-8-yl)amino)pentyl)hydrazinecarboxamide

2-(1H-benzo[d][1,2,3]triazole-1-carbonyl)-N-(4-((6-methoxyquinolin-8-yl)amino)pentyl)hydrazinecarboxamide

primaquine diphosphate
63-45-6

primaquine diphosphate

N,N-bis(4-((6-methoxyquinolin-8-yl)amino)pentyl)hydrazine-1,2-dicarboxamide

N,N-bis(4-((6-methoxyquinolin-8-yl)amino)pentyl)hydrazine-1,2-dicarboxamide

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; diethyl ether68%
dispiro[adamantane-2,2'-[1,3,5]trioxolane-4',1"-cyclohexane]-3"-yl 4-nitrophenylcarbonate

dispiro[adamantane-2,2'-[1,3,5]trioxolane-4',1"-cyclohexane]-3"-yl 4-nitrophenylcarbonate

primaquine diphosphate
63-45-6

primaquine diphosphate

dispiro[adamantane-2,2'-[1,3,5]trioxolane-4',1"-cyclohexane]-3"-yl N-{4-[(6-methoxyquinolin-8-yl)amino]pentyl}carbamate

dispiro[adamantane-2,2'-[1,3,5]trioxolane-4',1"-cyclohexane]-3"-yl N-{4-[(6-methoxyquinolin-8-yl)amino]pentyl}carbamate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 18h;68%
2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-(4-bromophenyl)-2-(4-chlorophenyl)acetamide

2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-(4-bromophenyl)-2-(4-chlorophenyl)acetamide

primaquine diphosphate
63-45-6

primaquine diphosphate

N-(4-bromophenyl)-2-(4-chlorophenyl)-2-[({4-[(6-methoxyquinolin-8-yl)amino]pentyl}carbamoyl)amino]acetamide

N-(4-bromophenyl)-2-(4-chlorophenyl)-2-[({4-[(6-methoxyquinolin-8-yl)amino]pentyl}carbamoyl)amino]acetamide

Conditions
ConditionsYield
Stage #1: primaquine diphosphate With sodium hydroxide In water pH=9 - 10;
Stage #2: 2-[(1H-1,2,3-benzotriazole-1-carbonyl)amino]-N-(4-bromophenyl)-2-(4-chlorophenyl)acetamide In 1,4-dioxane at 20℃; Darkness;
67%

Primaquine diphosphate Specification

The IUPAC name of Primaquine phosphate is 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid. With the CAS registry number 63-45-6 and EINECS 200-560-8, it is also named as (+-)-8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline phosphate (1:2). The classification codes are Antimalarial; Drug / Therapeutic Agent; Mutation data; Reproductive Effect. It is orange powder which is is highly toxic and flammable. When heated to decomposition it emits toxic fumes of NOx and POx. So the storage environment should be well-ventilated, low-temperature and dry.

The other characteristics of this product can be summarized as: (1)ACD/LogP: 1.53; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -1.6; (4)ACD/LogD (pH 7.4): -1.19; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 4; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 7; (12)Polar Surface Area: 28.6 Å2; (13)Enthalpy of Vaporization: 71.01 kJ/mol; (14)Vapour Pressure: 2.5E-08 mmHg at 25°C; (15)Rotatable Bond Count: 6; (16)Exact Mass: 455.122253; (17)MonoIsotopic Mass: 455.122253; (18)Topological Polar Surface Area: 216; (19)Heavy Atom Count: 29; (20)Complexity: 312.

Uses of Primaquine phosphate: It is an aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It can also be used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. The adverse effects include anemias and GI disturbances.

When you are using this chemical, please be cautious about it as the following:
It is toxic if swallowed. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)

People can use the following data to convert to the molecule structure. 
1. SMILES:O=P(O)(O)O.O=P(O)(O)O.O(c1cc(NC(C)CCCN)c2ncccc2c1)C
2. InChI:InChI=1/C15H21N3O.2H3O4P/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14;2*1-5(2,3)4/h4,6,8-11,18H,3,5,7,16H2,1-2H3;2*(H3,1,2,3,4) 
3. InChIKey:GJOHLWZHWQUKAU-UHFFFAOYAE

The following are the toxicity data which has been tested.

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
bird - domestic LD50 intravenous 19300ug/kg (19.3mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1775, 1970.
mouse LD50 intraperitoneal 105mg/kg (105mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1775, 1970.
mouse LD50 oral 68mg/kg (68mg/kg)   Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol. 74, Pg. 43, 1980.
rat LD50 oral 177mg/kg (177mg/kg)   Journal of Medicinal Chemistry. Vol. 32, Pg. 1728, 1989.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View